» Articles » PMID: 34965413

Imaging Transcriptomics: Convergent Cellular, Transcriptomic, and Molecular Neuroimaging Signatures in the Healthy Adult Human Brain

Overview
Journal Cell Rep
Publisher Cell Press
Date 2021 Dec 29
PMID 34965413
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The integration of transcriptomic and neuroimaging data, "imaging transcriptomics," has recently emerged to generate hypotheses about potential biological pathways underlying regional variability in neuroimaging features. However, the validity of this approach is yet to be examined in depth. Here, we sought to bridge this gap by performing transcriptomic decoding of the regional distribution of well-known molecular markers spanning different elements of the biology of the healthy human brain. Imaging transcriptomics identifies biological and cell pathways that are consistent with the known biology of a wide range of molecular neuroimaging markers. The extent to which it can capture patterns of gene expression that align well with elements of the biology of the neuroinflammatory axis, at least in healthy controls without a proinflammatory challenge, is inconclusive. Imaging transcriptomics might constitute an interesting approach to improve our understanding of the biological pathways underlying regional variability in a wide range of neuroimaging phenotypes.

Citing Articles

Multiscale brain modeling: bridging microscopic and macroscopic brain dynamics for clinical and technological applications.

Krejcar O, Namazi H Front Cell Neurosci. 2025; 19:1537462.

PMID: 40046848 PMC: 11879965. DOI: 10.3389/fncel.2025.1537462.


Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimaging.

Giacomel A, Martins D, Nordio G, Easmin R, Howes O, Selvaggi P Mol Psychiatry. 2025; .

PMID: 40021831 DOI: 10.1038/s41380-025-02938-w.


A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET Imaging.

Maccioni L, Brusaferri L, Barzon L, Schubert J, Nettis M, Cousins O Res Sq. 2025; .

PMID: 39975931 PMC: 11838776. DOI: 10.21203/rs.3.rs-5924801/v1.


Hippocampal gray matter volume alterations in patients with first-episode and recurrent major depressive disorder and their associations with gene profiles.

Sun F, Shuai Y, Wang J, Yan J, Lin B, Li X BMC Psychiatry. 2025; 25(1):134.

PMID: 39955494 PMC: 11829352. DOI: 10.1186/s12888-025-06562-4.


Molecular architecture of the altered cortical complexity in autism.

Mamat M, Chen Y, Shen W, Li L Mol Autism. 2025; 16(1):1.

PMID: 39763008 PMC: 11705879. DOI: 10.1186/s13229-024-00632-2.